04/26/2024
3:12 PM | Nektar Therapeutics (Filer)
| Form ARS | |
04/17/2024
4:03 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
3:38 PM | Nektar Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/15/2024
3:18 PM | Nektar Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
| Form SC 13G | |
03/14/2024
3:30 PM | Deep Track Biotechnology Master Fund, Ltd. (Reporting)
Deep Track Capital, LP (Reporting)
KROIN DAVID (Reporting)
Nektar Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/05/2024
4:11 PM | Nektar Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2024
3:20 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
03/04/2024
7:40 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
7:16 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:17 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:19 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
2:50 PM | Nektar Therapeutics (Subject)
Zalevsky Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
2:51 PM | Nektar Therapeutics (Subject)
Wilson Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
4:16 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:50 AM | Deep Track Capital, LP (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G/A | |
01/10/2024
3:25 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
5:05 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
5:05 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
5:07 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
11:18 AM | Nektar Therapeutics (Subject)
WHITFIELD ROY A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2023
3:55 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
7:58 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
8:00 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
8:02 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
3:36 PM | Nektar Therapeutics (Subject)
Zalevsky Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023
3:21 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/21/2023
7:07 PM | GREER R SCOTT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
7:06 PM | Ajer Jeffrey Robert (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
7:07 PM | Brainard Diana (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
7:08 PM | CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
7:09 PM | Curet Myriam (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
7:11 PM | Nektar Therapeutics (Issuer)
WHITFIELD ROY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
4:06 PM | CHESS ROBERT (Reporting)
Nektar Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/08/2023
4:16 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/17/2023
7:06 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
7:07 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
7:08 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
3:30 PM | Nektar Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
08/11/2023
8:31 PM | Nektar Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/07/2023
5:40 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
1:09 PM | Invesco Ltd. (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G/A | |
These AI trades triggered this morning (545% return) (Ad) If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy |
07/10/2023
9:41 AM | Nektar Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
07/07/2023
12:28 PM | Nektar Therapeutics (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
| Form SC 13G/A | |
07/03/2023
3:02 PM | CITADEL ADVISORS LLC (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G | |
06/22/2023
7:12 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
5:26 PM | Nektar Therapeutics (Issuer)
WHITFIELD ROY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:15 PM | Nektar Therapeutics (Subject)
WHITFIELD ROY A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2023
7:28 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
7:29 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
7:27 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
10:52 AM | BlackRock Inc. (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G/A | |
